Directory

>

Daniel Nomura

avatar

Daniel Nomura

Co-Founder | Frontier Medicines

Berkeley, California, United States

View contact details (it's free)

Daniel Nomura

Summary

Daniel Nomura is a distinguished Professor of Chemical Biology and Molecular Therapeutics at the University of California, Berkeley, with a focus on innovative therapeutic strategies for addressing complex diseases. He co-directs the Molecular Therapeutics Initiative and leads the Novartis-Berkeley Translational Chemical Biology Institute, where he explores the use of chemoproteomics in drug discovery. As a co-founder of Frontier Medicines and Vicinitas Therapeutics, he is at the forefront of developing next-generation therapies targeting the undruggable proteome. His academic journey includes a Ph.D. in Molecular Toxicology from UC Berkeley and a postdoctoral fellowship at Scripps Research. Daniel's work has garnered numerous accolades, including the National Cancer Institute Outstanding Investigator Award and the Searle Scholar Award. Beyond academia, he serves on several scientific advisory boards and is an investment advisory partner, bridging the gap between research and practical application in the biotech sector. His extensive publication record reflects his commitment to advancing the field of chemical biology.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Startup Experience

Daniel Nomura

Work Experience

company logo

Co-Founder at

Peter Bankowski, Uwe Harste, Thomas Marquardt und Peter Levin

August 2024 - Present

company logo

Co-Director of the Molecular Therapeutics Initiative at

Molecular Therapeutics Initiative

January 2024 - Present

company logo

iPartner at

The Column Group

August 2023 - Present

company logo

Advisory Partner at

Andreessen Horowitz

March 2023 - Present

company logo

Investment Advisory Board Member at

Droia Ventures

November 2022 - Present

company logo

Professor of Chemical Biology and Molecular Therapeutics at

The University California Berkeley

July 2022 - Present

company logo

Founder, Scientific Adviser, and Board Member at

Vicinitas Therapeutics, Inc.

May 2022 - Present

💼

Director at

Novartis Berkeley Translational Chemical Biology Institute

July 2017 - Present

company logo

Co-Founder and Scientific Adviser at

Frontier Medicines

June 2017 - Present

company logo

Adjunct Professor at

University of California, San Francisco

March 2016 - Present

company logo

Professor at

The University California Berkeley

July 2019 - June 2022

company logo

Associate Professor at

The University California Berkeley

July 2015 - July 2019

company logo

Assistant Professor at

The University California Berkeley

July 2011 - July 2015

company logo

Postdoctoral Fellow at

The Scripps Research Institute

July 2008 - July 2011

company logo

Graduate Student Researcher at

The University California Berkeley

August 2004 - June 2008

company logo

Undergraduate Reseacher at

The University California Berkeley

June 2000 - July 2004

Logos provided by Logo.dev

Daniel Nomura

Education

University of California, Berkeley, Doctor Of Philosophy - Phd

January 2004 - January 2008

University of California, Berkeley, Bachelor Of Arts - Ba

January 1999 - January 2003

Frequently Asked Questions about Daniel Nomura

What is Daniel Nomura email address?

Daniel Nomura's primary email address is ******@thecolumngroup.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Daniel Nomura work for?

Daniel Nomura is a Co-Founder at Frontier Medicines, a company specializing in Commercial physical research.

Where Daniel Nomura graduated from?

Daniel Nomura holds a degree in Molecular Toxicology from University of California, Berkeley.

How can I directly contact Daniel Nomura?

To contact Daniel Nomura directly, you can use the email address ******@thecolumngroup.com. Complete contact information is available upon registration with Muraena.

Who is Daniel Nomura?

Daniel Nomura is a distinguished Professor of Chemical Biology and Molecular Therapeutics at the University of California, Berkeley, with a focus on innovative therapeutic strategies for addressing complex diseases. He co-directs the Molecular Therapeutics Initiative and leads the Novartis-Berkeley Translational Chemical Biology Institute, where he explores the use of chemoproteomics in drug discovery. As a co-founder of Frontier Medicines and Vicinitas Therapeutics, he is at the forefront of developing next-generation therapies targeting the undruggable proteome. His academic journey includes a Ph.D. in Molecular Toxicology from UC Berkeley and a postdoctoral fellowship at Scripps Research. Daniel's work has garnered numerous accolades, including the National Cancer Institute Outstanding Investigator Award and the Searle Scholar Award. Beyond academia, he serves on several scientific advisory boards and is an investment advisory partner, bridging the gap between research and practical application in the biotech sector. His extensive publication record reflects his commitment to advancing the field of chemical biology.

Daniel`s contact details

mail

******@thecolumngroup.com

*******@berkeley.edu

Colleagues

avatar
Norbert Schuehler

VP, Information Technology

avatar
Snahel Patel

Vice President, Head of Chemistry

avatar
Sylvia

Chief Of Staff

avatar
Roberto Zoncu

Co-director, Molecular Therapeutics Initiative

Doug Burdette

Vice President of DMPK

Daniel Erlanson

Chief Innovation Officer

avatar
Tina Gullotta

Vice President Finance

Kevin Webster

Chief Science Officer

avatar
Johannes Hermann

Chief Technology Officer

avatar
Victoria Fort

Senior Vice President, Strategy and Corporate Affairs

View Contact details (it's free)
Request Profile Removal